Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.81% |
| 2 | Technology | 2.36% |
| 3 | Consumer Discretionary | 1.65% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHCR
11076
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $70.3K | ﹤0.01% |
74,741
-154,821
| -67% | -$185K |
|
|
TLIS
11077
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $70K | ﹤0.01% |
12,166
+11,468
| +1,643% | +$78.4K |
|
11078
PUT
Relmada Therapeutics
RLMD
$483M
| $69.9K | ﹤0.01% |
23,300
-26,800
| -53% | -$79.6K |
|
|
PCTI
11079
CALL
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $69.9K | ﹤0.01% |
+16,800
| New | +$75K |
|
11080
Scilex Holding
SCLX
$39.4M
| $69.3K | ﹤0.01% |
1,415
+607
| +75% | +$83.2K |
|
11081
CALL
Cognyte Software
CGNT
$664M
| $69.3K | ﹤0.01% |
+14,400
| New | +$73K |
|
11082
PUT
AvePoint
AVPT
$3.03B
| $69.2K | ﹤0.01% |
10,300
| – | – |
|
|
TTOO
11083
DELISTED
T2 Biosystems, Inc
TTOO
| $69.2K | ﹤0.01% |
3,133
+2,715
| +650% | +$70.8K |
|
11084
CALL
CPS Technologies
CPSH
$75.8M
| $68.9K | ﹤0.01% |
24,800
-14,900
| -38% | -$42K |
|
|
DZSI
11085
CALL
DELISTED
DZS Inc. Common Stock
DZSI
| $68.9K | ﹤0.01% |
32,800
-1,200
| -4% | -$3.45K |
|
11086
CALL
Quantum-Si Incorporated
QSI
$178M
| $68.7K | ﹤0.01% |
+41,400
| New | +$99.7K |
|
|
EFXT
11087
Enerflex
EFXT
$2.51B
| $68.6K | ﹤0.01% |
+11,976
| New | +$80.5K |
|
11088
Veru
VERU
$46.9M
| $68.6K | ﹤0.01% |
9,537
-13,627
| -59% | -$148K |
|
|
IDEX
11089
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $68.4K | ﹤0.01% |
28,140
+16,848
| +149% | +$113K |
|
|
NINE
11090
PUT
DELISTED
Nine Energy Service
NINE
| $67.6K | ﹤0.01% |
16,400
-2,200
| -12% | -$9.9K |
|
11091
PUT
BioVie
BIVI
$18M
| $67.5K | ﹤0.01% |
+198
| New | +$77.4K |
|
11092
CALL
Expensify
EXFY
$233M
| $67.3K | ﹤0.01% |
+20,700
| New | +$112K |
|
11093
CALL
Grove Collaborative
GROV
$42.4M
| $67K | ﹤0.01% |
25,200
-1,200
| -5% | -$3.04K |
|
|
FARM
11094
DELISTED
Farmer Brothers
FARM
| $67K | ﹤0.01% |
25,974
-1,472
| -5% | -$3.85K |
|
11095
PUT
ADMA Biologics
ADMA
$2.11B
| $66.9K | ﹤0.01% |
18,700
-13,800
| -42% | -$53.1K |
|
11096
Invesco Municipal Income Opportunities Trust
OIA
$290M
| $66.9K | ﹤0.01% |
11,513
-1,139
| -9% | -$7.04K |
|
11097
Mustang Bio
MBIO
$4.17M
| $66.9K | ﹤0.01% |
+652
| New | +$127K |
|
|
KZR
11098
DELISTED
Kezar Life Sciences
KZR
| $66.4K | ﹤0.01% |
5,582
-2,189
| -28% | -$38.8K |
|
11099
Mistras Group
MG
$612M
| $66.4K | ﹤0.01% |
12,189
-9,632
| -44% | -$60.5K |
|
|
RENT
11100
CALL
Rent the Runway
RENT
$119M
| $66.4K | ﹤0.01% |
4,880
+965
| +25% | +$27.5K |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.